[1] del Rey A, Yau HJ, Randolf A, et al. Chronic neuropathic pain-like behavior correlates with IL-1beta expression and disrupts cytokine interactions in the hippocampus. Pain.2011; 152(12):2827-2835.
[2] Ellis A, Bennett DL. Neuroinflammation and the generation of neuropathic pain. Br J Anaesth. 2013; 111(1):26-37.
[3] Kepler CK,Markova DZ,Dibra F,et al.Expression and relationship of proinflammatory chemokine RANTES/CCL5 and cytokine IL-1beta in painful human intervertebral discs. Spine. 2013; 38(11):873-880.
[4] Kiguchi N,Maeda T, Kobayashi Y, et al. Macrophage inflammatory protein-1alpha mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1beta up-regulation. Pain. 2010; 149(2):305-315.
[5] Salvi J, Bertaso F, Mausset-Bonnefont AL, et al. RNAi silencing of P/Q-type calcium channels in Purkinje neurons of adult mouse leads to episodic ataxia type 2. Neurobiol Dis. 2014; 68C:47-56.
[6] Wang Q, Wang X,Zhai X,et al.Construction and identification of an RNA interference lentivirus vector targeting the Ras homology C gene of melanoma cells. Chin Med J (Engl).2014; 127(7): 1339-1343.
[7] Nicolson SC, Samulski RJ. Recombinant adeno-associated virus utilizes host cell nuclear import machinery to enter the nucleus.J Virol.2014; 88(8):4132-4144.
[8] van Gestel MA, van Erp S, Sanders LE, et al. shRNA-induced saturation of the microRNA pathway in the rat brain. Gene Ther. 2014; 21(2):205-211.
[9] Hu B, Zhang Y, Zeng Q, et al.Intravitreal injection of ranibizumab and CTGF shRNA improves retinal gene expression and microvessel ultrastructure in a rodent model of diabetes. Int J Mol Sci.2014; 15(1):1606-1624.
[10] Yano R, Ma L, Nagai J, et al. Interleukin-1beta plays key roles in LPA-induced amplification of LPA production in neuropathic pain model. Cell Mol Neurobiol. 2013; 33(8):1033-1041.
[11] Chen YW,Tzeng JI,Lin MF,et al.Forced treadmill running suppresses postincisional pain and inhibits upregulation of substance P and cytokines in rat DRG. J Pain.2014; 15(8): 827-834.
[12] Kim MJ,Lee SY,Yang KY,et al.Differential regulation of peripheral IL-1beta-induced mechanical allodynia and thermal hyperalgesia in rats. Pain. 2014; 155(4):723-732.
[13] Mei XP, Sakuma Y, Xie C, et al. Depressing Interleukin-1beta Contributed to the Synergistic Effects of Tramadol and Minocycline on Spinal Nerve Ligation-Induced Neuropathic Pain. Neurosignals. 2013; 22(1):30-42.
[14] Kim WJ, Kang H, Choi GJ, et al. Antihyperalgesic effects of ginseng total saponins in a rat model of incisional pain. J Surg Res. 2014; 187(1):169-175.
[15] Bapat VA. Recent Advances in Ribonucleic Acid Interference (RNAi). National Academy Science Letters. 2013; 36(1):1-8.
[16] Karlsson C, Rak J, Larsson J. RNA interference screening to detect targetable molecules in hematopoietic stem cells. Curr Opin Hematol.2014;21(4):283-288.
[17] Tan PH,Gao YJ,Berta T,et al.Short small-interfering RNAs produce interferon-alpha-mediated analgesia. Br J Anaesth. 2012; 108(4):662-669.
[18] Garraway SM, Xu Q, Inturrisi CE. siRNA-mediated knockdown of the NR1 subunit gene of the NMDA receptor attenuates formalin-induced pain behaviors in adult rats. J Pain.2009; 10(4):380-390.
[19] Tan PH, Yu SW, Lin VC, et al. RNA interference-mediated gene silence of the NR1 subunit of the NMDA receptor by subcutaneous injection of vector-encoding short hairpin RNA reduces formalin-induced nociception in the rat. Pain. 2011; 152(3):573-581.
[20] Guo J, Gao J, Li Z, et al. Adenovirus vector-mediated Gli1 siRNA induces growth inhibition and apoptosis in human pancreatic cancer with Smo-dependent or Smo-independent Hh pathway activation in vitro and in vivo. Cancer Lett. 2013; 339(2):185-194.
[21] Wang H,Yang B,Qiu L, et al. Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis. Hum Mol Genet.2014; 23(3):668-681.
[22] Dhamne H, Chande AG, Mukhopadhyaya R. Lentiviral vector platform for improved erythropoietin expression concomitant with shRNA mediated host cell elastase down regulation. Plasmid. 2014; 71:1-7.
[23] Machitani M,Sakurai F,Katayama K,et al. Improving adenovirus vector-mediated RNAi efficiency by lacking the expression of virus-associated RNAs.Virus Res. 2013; 178(2): 357-363.
[24] Machida A,Kuwahara H,Mayra A,et al.Intraperitoneal administration of AAV9-shRNA inhibits target gene expression in the dorsal root ganglia of neonatal mice. Mol Pain. 2013; 9:36.
[25] Kreppel F. Production of high-capacity adenovirus vectors. Methods Mol Biol. 2014; 1089:211-229. |